Teva, the patent suit expert, achieves the first ‘winning’ against AZ in Korea

Teva, which grew its body through patent lawsuits in the U.S., announced the first ‘winning’ of a lawsuit in Korea.

Teva-Handok, jointly established in Korea by Teva and Handok, succeeded in avoiding 3 formulation patents of Symbicort Turbuhaler(AstraZeneca) by the defensive confirmation trial for the scope of the right on the 19^th.

Symbicort Turbuhaler is an AstraZeneca’s inhalation-type lun...